Ninety-nine patients with advanced breast cancer were randomized to receive either cyclophosphamide continuously or a combination of cyclophosphamide, methotrexate, 5-fluorouracil and vinblastine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results